A metastable polymorph of metformin hydrochloride: Isolation and characterization using capillary crystallization and thermal microscopy techniques

Crystal Growth and Design

Volumn 4, Issue 3, 2004, Pages 441-449

  Childs, Scott L ^b   Chyall, Leonard J ^a   Dunlap, Jeanette T ^a   Coates, David A ^a   Stahly, Barbara C ^a   Stahly, G Patrick ^a  

^a SSCI Incorporated   (United States)

^b Design Science Research LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; HYDROGEN BOND; MICROSCOPY; SOLID; THERMODYNAMICS; THERMOSTABILITY;

EID: 2542621252     PISSN: 15287483     EISSN: None     Source Type: Journal    
DOI: 10.1021/cg034243p     Document Type: Article

References (40)

1. International Conference on Harmonisation; Guidance on Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. Fed. Regist. 2000, 65 (251), 83041-83063.
2. Guillory J. Generation of Polymorphs, Hydrates, Solvates, and Amorphous Solids. In Polymorphism in Pharmaceutical Solids; Brittain, HG, Ed.; Marcel Dekker: New York, 1999; pp 183-226.
3. Chemburkar, S. R.; Bauer, J.; Deming, K.; Spiwek, H.; Patel K.; Morris, J.; Henry, R.; Spanton, S.; Dziki, W.; Porter, W.; Quick, J.; Bauer, P.; Donaubauer, J.; Narayanan, B. A.; Soldani, M.; Riley, D.; McFarland, K. Org. Process Res. Dev. 2000, 4, 413-417.
4. Chyall, L. J.; Tower, J. M.; Coates, D. A.; Houston, T. L.; Childs, S. L. Cryst. Growth Des. 2002, 2, 505-510.
5. (a) Morris, K. R.; Stahly, G. P. WO 02/054043 A2, 2002.
6. (b) Hilden, J. L.; Reyes, C. E.; Keim, M. J.; Tan, J. S.; Stowell, J. G.; Morris, K. R. Cryst. Growth Des. 2003, 6, 921-926.
7. (c) Ng, J. D.; Gavira, J. A.; Garcia-Ruiz, J. M. J. Struct. Biol. 2002, 142, 218-231.
8. (a) Biertumpfel, C.; Basquin, J.; Suck, D.; Sauter, C. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2002, 58, 1657-1659.
9. (b) Garcia-Ruiz, J. M.; Moreno, A.; Viedma, C.; Coll, M. Mater. Res. Bull. 1993, 28, 541-546.
10. Zhou, D. L.; Zhang, G. G. Z.; Law, D.; Grant, D. J. W.; Schmitt, E. A. J. Pharm. Sci. 2002, 91, 1863-1872.
11. Bretnall, A. E.; Clarke, G. S. Anal. Profiles Drug Subst. Excipients 1998, 25, 246-281.
12. SMART Version 5.624, Bruker AXS, Inc., Analytical X-ray Systems, 5465 East Cheryl Parkway, Madison, WI, 2000.
13. SAINT Version 6.02, Bruker AXS, Inc., Analytical X-ray Systems, 5465 East Cheryl Parkway, Madison WI, 2000.
14. SADABS Version 2.03, George Sheldrick, University of Göttingen, 2001.
15. SHELXTL V5.10, Bruker AXS, Inc., Analytical X-ray Systems, 5465 East Cheryl Parkway, Madison WI, 2000.
16. International Tables for X-ray Crystallography, Volume C. Wilson, A. J. C., Ed.; Kynoch, Academic Publishers: Dordrecht, 1992; Tables 6.1.1.4 (pp 500-502) and 4.2.6.8 (pp 219-222).
17. (a) Nolze, G.; Kraus, W. PowderCell 2.3, Federal Institute of Materials Research and Testing: Berlin, Germany, 1998.
18. (b) Nolze, G.; Kraus, W. J. Appl. Crystallogr. 1996 29, 301-303.
19. Hariharan, M.; Rajan, S. S.; Srinivasan, R. Acta Crystallogr., Sect. C: Cryst. Struct. Commun. 1989, 45, 911-913.
20. Tovbin, Y. K.; Tugazakov, R. Y.; Komarov, V. N. Colloids Surf., A 2002, 206, 377-392.
21. Kuhnert-Brandstatter, M.; Geiler, M.; Wurian, I. Sci. Pharm. 1983, 51, 34-41.
22. Gavezzotti, A.; Filippini, G. J. Am. Chem. Soc. 1995, 117, 12299-12305.
23. Davey, R. J.; Allen, K.; Blagden, N.; Cross, W. I.; Lieberman, H. F.; Quayle, M. J.; Righini, S.; Seton, L.; Tiddy, G. J. T. CrystEngComm 2002, 257-264.
24. (a) Mullin, J. W. Crystallization; 4th ed.; Butterworth-Heinemann: Oxford, 2001.
25. (b) Kumar, R. M.; Gopalakrishnan, N.; Jayavel, R.; Ramasamy, P. Cryst. Res. Technol. 1999, 34, 1265-1268.
26. (c) Hasznos-Nezdei, M.; Liszi, I.; Lakatos, B. G. Chem. Eng. Technol. 2003, 26, 359-362.
27. (d) Kashchiev, D.; van Rosmalen, G. M. Cryst. Res. Technol. 2003, 38, 555-574.
28. (e) Kumar, R. M.; Gopalakrishnan, N.; Jayavel, R.; Ramasamy, P. Cryst. Res. Technol. 1999, 34, 1265-1268.
29. (f) Bernstein, J.; Davey, R. J.; Henck, J. O. Angew. Chem., Int. Ed. 1999, 38, 3441-3461.
30. (g) Bernstein, J. Polymorphism in Molecular Crystals; Clarendon Press: Oxford, 2002.
31. Mersmann, A. J. Cryst. Growth 1990, 102, 841-847.
32. (a) Kitamura, M. J. Cryst. Growth 2002, 237, 2205-2214.
33. (b) ter Horst, J. H.; Kramer, H. J. M.; Jansens, P. J. Cryst. Growth Des. 2002, 2, 351-356.
34. (a) Miura, H. U. T.; Nagai, K.; Fujimoto, D.; Lepp, Z.; Takahashi, H.; Tamura, R. Cryst. Growth Des. 2003, 3, 959-965.
35. (b) Bartolomei, M.; Bertocchi, P.; Ramusino, M. C.; Santucci, N.; Valvo, L. J. Pharm. Biomed. Anal. 1999, 21, 299-309.
36. (c) Tong, H. H. Y.; Shekunov, B. Y.; York, P.; Chow, A. H. L. Pharm. Res. 2001, 18, 852-858.
37. (d) Urakami, K.; Shono, Y.; Higashi, A.; Umemoto, K.; Godo, M. Bull. Chem. Soc. Jpn. 2002, 75, 1241-1245.
38. (e) Shah, J. C.; Chen, J. R.; Chow, D. Drug Dev. Ind. Pharm. 1999, 25, 63-67.
39. Threlfall, T. Org. Proc. Res. Dev. 2000, 4, 384-390.
40. Gu, C. H.; Young, V.; Grant, D. J. W. J. Pharm. Sci. 2001, 90, 1878-1890.